Science News for July 22, 2017

World-first ketamine trial shows promise for geriatric depression

Researchers have conducted the world's first randomised control trial assessing ketamine's effectiveness as an antidepressant in elderly patients. The trial found that repeated intravenous doses of ketamine resulted in a 68.8% response and remission rate among patients, with no severe side effects reported.

SourceUniversity of New South Wales·JournalAmerican Journal of Geriatric Psychiatry·DateJul 22, 2017

Patients taking opioids prior to ACL surgery more likely to be on pain medications longer

Patients taking opioids prior to ACL surgery are more likely to be on pain medications longer, according to a recent study. The research found that those who were filling opioid prescriptions before surgery were 10 times more likely to be using them five months after surgery.

SourceAmerican Orthopaedic Society for Sports Medicine·DateJul 22, 2017

Patients with irreparable rotator cuff tears may have surgical option, new research shows

A new arthroscopic technique allows patients with irreparable rotator cuff tears to regain shoulder function and return to sports or jobs requiring heavy physical activity. The study showed significant improvement in shoulder range of motion after surgery.

SourceAmerican Orthopaedic Society for Sports Medicine·DateJul 22, 2017

Apple iPhone 17 Pro

Apple iPhone 17 Pro delivers top performance and advanced cameras for field documentation, data collection, and secure research communications.